Despite any lingering post-pandemic fatigue, Australian health officials and the general public alike are anticipated to remain vigilant for any new developments in respiratory illness over the forecast period. Influenza and RSV symptoms are already extensively tracked and exhaustively reported in the media, with attention on any unexpected developments, such as spikes in whooping cough or the emergence of human cases of avian influenza A (H5N1) infection.
Hay fever (allergic rhinitis) is a common condition in Australia, estimated to affect approximately 19% of the population, and is driving increasing demand for antihistamines/allergy remedies. This figure is expected to increase over the forecast period and beyond.
Retailers of consumer health products are currently awaiting the decision from the Australian Competition and Consumer Commission (ACCC) as to whether it will approve the proposed merger of Chemist Warehouse and Sigma Healthcare, which would impact sales of cough, cold and allergy (hay fever) remedies in Australia, and indeed much of the future of the consumer health retail ecosystem. Proposed in December 2023, the deal would introduce Chemist Warehouse to a public listing on the Australian Securities Exchange (ASX) through Sigma, and potentially span an enormous network of 864 outlets under the Chemist Warehouse, MyChemist, Amcal and Discount Drug Stores brands, in addition to a large wholesale business.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Australia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Australia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Cough, Cold and Allergy (Hay Fever) Remedies
This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.
See All of Our DefinitionsThis report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!